Shares of staffing firm Cross Country Healthcare, Inc. (NASDAQ: CCRN) rose 27.04% in after market trades on Wednesday following announcement of financial results for its fourth quarter and full year ended December 31, 2020. Regular session saw the stock rising 5.67% to $10.06 at ring of the bell.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
What happened?
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A leader in the provision of total talent management services, Cross Country Healthcare provides an array of services to healthcare clients including contingent and permanent staffing, consulting services, and workforce solutions. CCRN provides outstanding patient care and high-quality outcomes by leveraging its 35 years of experience in the industry.
Read More
What financials say?
- In the fourth quarter, revenue was $215.6 million, the same as the same quarter last year.
- The company’s net income soared 503% to $4.6 million. Last year, the company lost -$1.1 million and in the prior quarter, the company lost $1.3 million.
- EPS for the quarter was $0.13 compared to losses of $0.03 per share in the year-ago quarter and $0.04 per share in the last quarter.
- Revenue for the full year 2020 increased by 2% to $836.4 million.
- A net loss of $13.0 million, or $0.36 per share was posted by the company, which was lesser than a loss of $57.7 million, or $1.61 per share in the prior year.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
- Earnings per share (EPS) increased from $0.15 in the 2019 to $0.46 in 2020 as adjusted EBITDA increased from $25.5 million to $36.3 million.